These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7723712)
21. [Effect of intracoronary dipyridamole administration on the incidence of restenosis after PTCA. A prospective randomized study]. Heidland UE; Klimek WJ; Michel CJ; Heintzen MP; Strauer BE Med Klin (Munich); 1998 Oct; 93(10):579-84. PubMed ID: 9849048 [TBL] [Abstract][Full Text] [Related]
22. Significance of ST alternans during percutaneous transluminal coronary angioplasty. Shah D; Subramanyan K Indian Heart J; 1995; 47(3):248-52. PubMed ID: 7558092 [TBL] [Abstract][Full Text] [Related]
23. [Results of coronary heart disease treatment with coronary angioplasty in patient over 65]. Chizyński K Przegl Lek; 2003; 60(7):456-60. PubMed ID: 14750418 [TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. Hombach V; Höpp HW; Fuchs M; Behrenbeck DW; Tauchert M; Hilger HH Herz; 1986 Aug; 11(4):232-6. PubMed ID: 2944807 [TBL] [Abstract][Full Text] [Related]
26. [The cardioprotective effect of verapamil in acute percutaneous transluminal coronary angioplasty]. Werner GS; Schmid M; Klein HH; Wiegand V; Kreuzer H; Tebbe U Z Kardiol; 1988 Nov; 77(11):728-35. PubMed ID: 2975091 [TBL] [Abstract][Full Text] [Related]
27. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. Leesar MA; Stoddard MF; Manchikalapudi S; Bolli R J Am Coll Cardiol; 1999 Sep; 34(3):639-50. PubMed ID: 10483942 [TBL] [Abstract][Full Text] [Related]
28. Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention. Ungi I; Pálinkás A; Nemes A; Ungi T; Thury A; Sepp R; Horváth T; Forster T; Végh A Can J Physiol Pharmacol; 2008 Dec; 86(12):827-34. PubMed ID: 19088803 [TBL] [Abstract][Full Text] [Related]
29. The effects of intracoronary adenosine on preconditioning during coronary angioplasty. Kerensky RA; Kutcher MA; Braden GA; Applegate RJ; Solis GA; Little WC Clin Cardiol; 1995 Feb; 18(2):91-6. PubMed ID: 7720296 [TBL] [Abstract][Full Text] [Related]
30. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial. Heintzen MP; Heidland UE; Klimek WJ; Leschke M; Kelm M; Schwartzkopff B; Vester EG; Michel CJ; Strauer BE Heart; 2000 May; 83(5):551-6. PubMed ID: 10768906 [TBL] [Abstract][Full Text] [Related]
31. Reactive hyperemia following coronary balloon angioplasty, but not dipyridamole-induced hyperemia, predicts resolution of exercise-induced ST-segment depression. Saihara K; Hamasaki S; Biro S; Kamekou M; Nakano F; Tsurugida M; Yoshitama T; Ishida S; Yoshikawa A; Kataoka T; Minagoe S; Tei C Coron Artery Dis; 2003 Nov; 14(7):501-7. PubMed ID: 14561943 [TBL] [Abstract][Full Text] [Related]
32. Intravenous dipyridamole-induced myocardial ischemia during percutaneous transluminal coronary angioplasty in humans. Klein AL; Marquis JF; Higginson LA; Morton BC; Williams WL; Davies RA; Beanlands DS Am J Cardiol; 1989 Feb; 63(7):419-22. PubMed ID: 2521767 [TBL] [Abstract][Full Text] [Related]
33. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? Billinger M; Fleisch M; Eberli FR; Garachemani A; Meier B; Seiler C J Am Coll Cardiol; 1999 Mar; 33(4):1027-35. PubMed ID: 10091831 [TBL] [Abstract][Full Text] [Related]
34. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Tomai F; Crea F; Gaspardone A; Versaci F; De Paulis R; Penta de Peppo A; Chiariello L; Gioffrè PA Circulation; 1994 Aug; 90(2):700-5. PubMed ID: 8044938 [TBL] [Abstract][Full Text] [Related]
35. Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans. Leesar MA; Stoddard MF; Xuan YT; Tang XL; Bolli R J Am Coll Cardiol; 2003 Aug; 42(3):437-45. PubMed ID: 12906969 [TBL] [Abstract][Full Text] [Related]
36. Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Friedman PL; Shook TL; Kirshenbaum JM; Selwyn AP; Ganz P Circulation; 1986 Aug; 74(2):330-9. PubMed ID: 2942314 [TBL] [Abstract][Full Text] [Related]
37. A mechanism of ischemic preconditioning during percutaneous transluminal coronary angioplasty. Inoue T; Fujito T; Hoshi K; Sakai Y; Yamaguchi H; Takayanagi K; Morooka S; Takabatake Y Cardiology; 1996; 87(3):216-23. PubMed ID: 8725317 [TBL] [Abstract][Full Text] [Related]
38. [Protection against ischemic damage during percutaneous coronary angioplasty]. Specchia G; Ghio S; Bramucci E; Angoli L; Raffaghello S; De Servi S Cardiologia; 1991 Dec; 36(12 Suppl 1):215-20. PubMed ID: 1688158 [TBL] [Abstract][Full Text] [Related]
39. Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCA. Saito K; Nonogi H; Goto Y; Itoh A; Daikoku S; Miyazaki S; Haze K Heart Vessels; 1996; 11(2):92-9. PubMed ID: 8836757 [TBL] [Abstract][Full Text] [Related]
40. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Leesar MA; Stoddard MF; Dawn B; Jasti VG; Masden R; Bolli R Circulation; 2001 Jun; 103(24):2935-41. PubMed ID: 11413083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]